Fund Details
BOI AXA Arbitrage Fund Direct Growth
| Risk | Low |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 0.21% |
| NAV | ₹11.39 (20 Jan 2021) |
|---|---|
| Fund Started | 18 Jun 2018 |
| Fund Size | ₹32 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| HDFC Bank Ltd. | Financial | Fixed Deposits | 3.6% |
| Hindustan Unilever Ltd. | FMCG | Equity | 3.0% |
| Infosys Ltd. | Technology | Equity | 2.6% |
| Dabur India Ltd. | FMCG | Equity | 2.5% |
| Housing Development Finance Corpn. Ltd. | Financial | Equity | 2.5% |
| ICICI Bank Ltd. | Financial | Equity | 2.4% |
| Cipla Ltd. | Healthcare | Equity | 2.4% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 2.2% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.2% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 2.2% |
Fund Managers
BOI AXA Arbitrage Fund Direct Growth Details
BOI AXA Arbitrage Fund Direct Growth is a Equity Mutual Fund Scheme launched by BOI AXA Mutual Fund. This scheme was made available to investors on 18 Jun 2018. Ajay Khandelwal is the Current Fund Manager of BOI AXA Arbitrage Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹32 Cr and the Latest NAV as of 20 Jan 2021 is ₹11.39.
The BOI AXA Arbitrage Fund Direct Growth is rated Low risk. Minimum Lumpsum Investment is 500. Exit load of 0.50% if redeemed within 30 days.
Investment Objective
The scheme seeks to generate income through arbitrage opportunities between cash and derivative segments of the equity market and arbitrage opportunities within the derivative segment and by deployment of surplus cash in debt securities and money market instruments.
